TOPIC

GROWTH STOCKS News & Analysis

Deliveries at Tesla fall for second straight quarter
Stocks
Deliveries at Tesla fall for second straight quarter
Tesla’s current product lineup may have reached market saturation. But investors have high hopes its robotaxi business.
Seth Goldstein, CFA | 04 July 2025
Ask the analyst: Can ASX growth story turn a profit before it’s too late?
Stocks
Ask the analyst: Can ASX growth story turn a profit before it’s too late?
This healthcare company still has plenty of growth potential, but it’s been a rocky road for investors recently.
Joseph Taylor | 01 July 2025
Expensive ASX star looks vulnerable to slowing sales growth
Stocks
Expensive ASX star looks vulnerable to slowing sales growth
Cochlear’s biggest market segment has matured and it is looking elsewhere for growth.
Shane Ponraj, CFA | 17 June 2025
7 lessons from one of the best stocks in history
Personal Finance
7 lessons from one of the best stocks in history
Monster's share price is up over 18 times since I first came across its products in the late noughties. What can we learn from its rise?
Joseph Taylor | 11 June 2025
Ask the analyst: Can Fineos emulate WiseTech’s niche success?
Stocks
Ask the analyst: Can Fineos emulate WiseTech’s niche success?
In the life insurance software industry, growth requires patience. Shaun Ler thinks this ASX listed firm is positioned to win.
Joseph Taylor | 11 June 2025
Is WiseTech’s $3.2 billion purchase the right move?
Stocks
Is WiseTech’s $3.2 billion purchase the right move?
WiseTech’s latest acquisition is bigger than its previous 55 combined. Integration could be challenging but the timing looks right.
Roy Van Keulen | 28 May 2025
ASX kingmaker stock upgraded to Wide Moat rating
Stocks
ASX kingmaker stock upgraded to Wide Moat rating
WiseTech’s competitive position is incredibly strong and looks set to underpin formidable sales growth for the foreseeable future.
Roy Van Keulen | 26 May 2025
The top shares of Australia’s best performing super funds
Retirement
The top shares of Australia’s best performing super funds
And our equity analysts’ outlook for the stocks.
Shani Jayamanne | 19 May 2025
ASX healthcare leader continues to prove the doubters wrong
Stocks
ASX healthcare leader continues to prove the doubters wrong
Niche play with more growth potential than many investors give it credit for.
Shane Ponraj, CFA | 28 April 2025
Netflix’s new growth targets look tough and may already be priced in
Stocks
Netflix’s new growth targets look tough and may already be priced in
Shares in the streaming giant don’t look especially cheap, even if management achieves its ambitious goals for 2030.
Matthew Dolgin, CFA | 16 April 2025